OGX-427

apatorsen · OncoGenex Pharmaceuticals

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for OGX-427, covering 2012-02-13 to 2019-02-15. Get the full timeline:

Most recent: Clinical Trial Update: OGX-427 in Castration Resistant Prostate Cancer Patients [Phase 2]